Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

[Biology of metastases and molecular mechanisms of their formation].

Coussy F, Bonin F, Azorin P, Tariq Z, Driouch K.

Bull Cancer. 2019 Jan;106(1):24-36. doi: 10.1016/j.bulcan.2018.11.010. Epub 2018 Dec 14. Review. French.

PMID:
30554635
2.

Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey.

Liu W, Vivian CJ, Brinker AE, Hampton KR, Lianidou E, Welch DR.

Cancer Microenviron. 2014 Dec;7(3):117-31. doi: 10.1007/s12307-014-0148-4. Epub 2014 Jun 18.

3.

The molecular biology of pulmonary metastasis.

Krishnan K, Khanna C, Helman LJ.

Thorac Surg Clin. 2006 May;16(2):115-24. Review.

PMID:
16805200
4.

A system for detecting high impact-low frequency mutations in primary tumors and metastases.

Anjanappa M, Hao Y, Simpson ER, Bhat-Nakshatri P, Nelson JB, Tersey SA, Mirmira RG, Cohen-Gadol AA, Saadatzadeh MR, Li L, Fang F, Nephew KP, Miller KD, Liu Y, Nakshatri H.

Oncogene. 2018 Jan 11;37(2):185-196. doi: 10.1038/onc.2017.322. Epub 2017 Sep 11.

5.

Clinical and molecular complexity of breast cancer metastases.

Kimbung S, Loman N, Hedenfalk I.

Semin Cancer Biol. 2015 Dec;35:85-95. doi: 10.1016/j.semcancer.2015.08.009. Epub 2015 Aug 28. Review.

6.

New insights into the mechanisms of organ-specific breast cancer metastasis.

Lorusso G, Rüegg C.

Semin Cancer Biol. 2012 Jun;22(3):226-33. doi: 10.1016/j.semcancer.2012.03.007. Epub 2012 Apr 5. Review.

PMID:
22504658
7.

Molecular insights into prostate cancer progression: the missing link of tumor microenvironment.

Chung LW, Baseman A, Assikis V, Zhau HE.

J Urol. 2005 Jan;173(1):10-20. Review.

PMID:
15592017
8.

Identification of metastasis driver genes by massive parallel sequencing of successive steps of breast cancer progression.

Krøigård AB, Larsen MJ, Lænkholm AV, Knoop AS, Jensen JD, Bak M, Mollenhauer J, Thomassen M, Kruse TA.

PLoS One. 2018 Jan 2;13(1):e0189887. doi: 10.1371/journal.pone.0189887. eCollection 2018.

9.

Thinking outside the box: using metastasis suppressors as molecular tools.

Thiolloy S, Rinker-Schaeffer CW.

Semin Cancer Biol. 2011 Apr;21(2):89-98. doi: 10.1016/j.semcancer.2010.12.008. Epub 2010 Dec 13. Review.

PMID:
21147228
10.

Translational Metabolomics of Head Injury: Exploring Dysfunctional Cerebral Metabolism with Ex Vivo NMR Spectroscopy-Based Metabolite Quantification.

Wolahan SM, Hirt D, Glenn TC.

In: Kobeissy FH, editor. Brain Neurotrauma: Molecular, Neuropsychological, and Rehabilitation Aspects. Boca Raton (FL): CRC Press/Taylor & Francis; 2015. Chapter 25.

11.

Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.

Marquardt S, Solanki M, Spitschak A, Vera J, Pützer BM.

Semin Cancer Biol. 2018 Dec;53:90-109. doi: 10.1016/j.semcancer.2018.06.006. Epub 2018 Jun 30. Review.

PMID:
29966677
12.

The use of molecular imaging combined with genomic techniques to understand the heterogeneity in cancer metastasis.

Chowdhury R, Ganeshan B, Irshad S, Lawler K, Eisenblätter M, Milewicz H, Rodriguez-Justo M, Miles K, Ellis P, Groves A, Punwani S, Ng T.

Br J Radiol. 2014 Jun;87(1038):20140065. doi: 10.1259/bjr.20140065. Epub 2014 Mar 6. Review.

13.

Key questions in metastasis: new insights in molecular pathways and therapeutic implications.

Gueron G, De Siervi A, Vazquez E.

Curr Pharm Biotechnol. 2011 Nov;12(11):1867-80. Review.

PMID:
21470130
14.

Metastasis suppressor genes: from gene identification to protein function and regulation.

Berger JC, Vander Griend DJ, Robinson VL, Hickson JA, Rinker-Schaeffer CW.

Cancer Biol Ther. 2005 Aug;4(8):805-12. Review.

PMID:
16082183
15.

Molecular networks that regulate cancer metastasis.

Spano D, Heck C, De Antonellis P, Christofori G, Zollo M.

Semin Cancer Biol. 2012 Jun;22(3):234-49. doi: 10.1016/j.semcancer.2012.03.006. Epub 2012 Mar 30. Review.

PMID:
22484561
16.

Heterogeneity of pancreatic cancer metastases in a single patient revealed by quantitative proteomics.

Kim MS, Zhong Y, Yachida S, Rajeshkumar NV, Abel ML, Marimuthu A, Mudgal K, Hruban RH, Poling JS, Tyner JW, Maitra A, Iacobuzio-Donahue CA, Pandey A.

Mol Cell Proteomics. 2014 Nov;13(11):2803-11. doi: 10.1074/mcp.M114.038547. Epub 2014 Jun 3.

17.

Predictive genomics: a cancer hallmark network framework for predicting tumor clinical phenotypes using genome sequencing data.

Wang E, Zaman N, Mcgee S, Milanese JS, Masoudi-Nejad A, O'Connor-McCourt M.

Semin Cancer Biol. 2015 Feb;30:4-12. doi: 10.1016/j.semcancer.2014.04.002. Epub 2014 Apr 18. Review.

PMID:
24747696
18.

Current concepts of tumour metastasis.

Barbour A, Gotley DC.

Ann Acad Med Singapore. 2003 Mar;32(2):176-84. Review.

PMID:
12772520
19.

Breast cancer and metastasis: on the way toward individualized therapy.

Trapé AP, Gonzalez-Angulo AM.

Cancer Genomics Proteomics. 2012 Sep-Oct;9(5):297-310. Review.

PMID:
22990109
20.

Theories on the metastatic process and possible therapeutic options.

Effert PJ, Strohmeyer TG.

Urol Res. 1995;23(1):11-9. Review.

PMID:
7618230

Supplemental Content

Support Center